Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

CME Group Inc Stock Research

CME

202.21USD-3.70(-1.80%)Market Closed
Watchlist

Market Summary

USD202.21-3.70
Market Closed
-1.80%

CME Alerts

  • 3 major insider sales recently.
  • Big jump in Revenue (Y/Y)

CME Stock Price

CME RSI Chart

CME Valuation

Market Cap

72.6B

Price/Earnings (Trailing)

24.37

Price/Sales (Trailing)

13.33

EV/EBITDA

16.82

Price/Free Cashflow

23.35

CME Price/Sales (Trailing)

CME Profitability

EBT Margin

75.70%

Return on Equity

10.46%

Return on Assets

1.72%

Free Cashflow Yield

4.28%

CME Fundamentals

CME Revenue

Revenue (TTM)

5.4B

Revenue Y/Y

446.6%

Revenue Q/Q

8.78%

CME Earnings

Earnings (TTM)

3.0B

Earnings Y/Y

17.37%

Earnings Q/Q

-12.02%

Price Action

52 Week Range

160.36209.31
(Low)(High)

Last 7 days

-0.7%

Last 30 days

1.6%

Last 90 days

13.1%

Trailing 12 Months

14.2%

CME Financial Health

Current Ratio

1.02

CME Investor Care

Dividend Yield

4.3%

Dividend/Share (TTM)

8.7

Shares Dilution (1Y)

0.08%

Diluted EPS (TTM)

8.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales

Latest Insider Trading transactions for CME

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-09-16
Sammann Derek
sold (taxes)
-62,252
206
-301
sr md gl hd commodity & option
2023-09-16
Cutinho Sunil
sold (taxes)
-62,252
206
-301
chief information officer
2023-09-16
Tobin Jack J
sold (taxes)
-9,720
206
-47.00
md chief accounting officer
2023-09-16
Fitzpatrick Lynne
sold (taxes)
-14,684
206
-71.00
sr md chief financial officer
2023-09-16
McCourt Timothy Francis
sold (taxes)
-16,752
206
-81.00
sr md global head equity & fx
2023-09-16
Sprague Suzanne
sold (taxes)
-18,407
206
-89.00
sr md global head of clearing
2023-09-16
Piell Hilda Harris
sold (taxes)
-55,220
206
-267
sr md & chief hr officer
2023-09-16
Winkler Julie
sold (taxes)
-58,736
206
-284
sr md chief commercial officer
2023-09-16
Vroman Ken
sold (taxes)
-21,716
206
-105
chief transformation officer
2023-09-16
Holzrichter Julie
sold (taxes)
-69,077
206
-334
sr md chief operating officer

1–10 of 50

Which funds bought or sold CME recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-14
IMS Capital Management
reduced
-1.42
-50,705
1,043,280
0.58%
2023-09-12
Farther Finance Advisors, LLC
reduced
-15.66
-19,355
85,789
0.02%
2023-09-08
TUCKER ASSET MANAGEMENT LLC
unchanged
-
-143
4,262
-%
2023-09-07
ST GERMAIN D J CO INC
new
-
4,882,210
4,882,210
0.26%
2023-09-07
ACADEMY CAPITAL MANAGEMENT INC/TX
reduced
-0.82
-94,991
2,242,010
0.45%
2023-09-05
Delos Wealth Advisors, LLC
unchanged
-
-374
11,118
0.01%
2023-08-29
EFG Asset Management (Americas) Corp.
reduced
-2.63
-527,544
8,570,620
1.98%
2023-08-29
Garde Capital, Inc.
unchanged
-
-4,000
111,000
0.01%
2023-08-25
Brown Shipley& Co Ltd
added
0.73
-35,671
1,362,810
0.56%
2023-08-24
INVICTUS PRIVATE WEALTH, LLC
unchanged
-
-8,566
254,774
0.03%

1–10 of 48

Latest Funds Activity

Are funds buying CME calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CME
No. of Funds

Schedule 13G FIlings of CME Group

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2023
capital world investors
4.4%
15,768,261
SC 13G/A
Feb 09, 2023
vanguard group inc
9.21%
33,139,178
SC 13G/A
Jan 31, 2023
blackrock inc.
7.2%
26,025,197
SC 13G/A
Feb 11, 2022
capital world investors
9.3%
33,473,618
SC 13G/A
Feb 09, 2022
vanguard group inc
8.72%
31,356,965
SC 13G/A
Feb 03, 2022
blackrock inc.
6.7%
24,162,418
SC 13G/A
Feb 16, 2021
capital world investors
9.5%
33,945,618
SC 13G/A
Feb 10, 2021
vanguard group inc
7.86%
28,231,615
SC 13G/A
Jan 29, 2021
blackrock inc.
7.0%
25,295,042
SC 13G/A
Feb 14, 2020
capital world investors
10.0%
35,842,471
SC 13G/A

Recent SEC filings of CME Group

View All Filings
Date Filed Form Type Document
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading
Sep 18, 2023
4
Insider Trading

CME Fair Value

Loading...

Peers (Alternatives to CME Group)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
72.6B
5.4B
1.63% 14.23%
24.37
13.33
39.96% 1.84%
64.6B
9.6B
1.31% 21.61%
38.27
6.75
1.00% -49.94%
24.8B
6.1B
-2.36% -14.58%
22.49
4.07
3.28% -2.99%
16.4B
3.9B
3.01% 30.91%
25.17
4.21
6.88% 207.99%
-
6.3B
1.12% -2.78%
-
-
-14.15% -36.16%
MID-CAP
9.4B
4.8B
-2.55% 34.55%
3.89
1.96
226.24% 90.31%
8.1B
1.9B
0.16% 14.72%
20.27
4.3
-8.00% -31.66%
7.0B
4.8B
3.49% 12.05%
11.36
1.45
2.69% -21.37%
2.0B
60.6B
-4.55% 12.08%
8.16
0.03
-1.46% 48.12%
SMALL-CAP
1.7B
1.9B
8.85% 32.11%
239.3
0.92
0.08% -93.14%
1.7B
2.2B
-7.59% -19.58%
8.51
0.76
-14.47% -57.71%
1.1B
1.5B
0.39% 32.10%
14.3
0.71
-27.22% -74.14%
809.1M
23.7M
1.46% -3.28%
44.23
34.21
51.04% 152.07%
415.0M
1.2B
-0.81% 14.64%
12.91
0.34
4.38% -66.00%
742.8M
313.5M
- -
14.66
2.47
0.19% 735.99%

CME Group News

Carbon Pulse
CP Daily: Thursday September 21, 2023 « Carbon Pulse.
Carbon Pulse,
20 minutes ago
GlobeNewswire
www.waterstechnology.com
Crain's Chicago Business
Cboe CEO's exit fuels CME merger speculation.
Crain's Chicago Business,
2 days ago

Returns for CME

Cumulative Returns on CME

15.2%


10-Year Cumulative Returns

13.4%


7-Year Cumulative Returns

6.6%


5-Year Cumulative Returns

10.5%


3-Year Cumulative Returns

Risks for CME

What is the probability of a big loss on CME?

43.1%


Probability that CME Group stock will be more than 20% underwater in next one year

9.2%


Probability that CME Group stock will be more than 30% underwater in next one year.

0%


Probability that CME Group stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CME drawdown profile look like?

Y-axis is the maximum loss one would have experienced if CME Group was unfortunately bought at previous high price.

Drawdowns

Financials for CME Group

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Last 12 Months)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Revenue30.8%5,4454,1645,0194,0093,8914,7834,6904,6414,6124,6154,8844,9245,1205,2114,8684,9664,5934,3804,3093,9733,959
Costs and Expenses1.7%2,0782,0442,0041,9801,9872,0042,0452,1122,1722,2122,2462,2282,2652,2942,2802,3022,0641,8821,7021,4781,447
EBITDA-100.0%-4,138--3,9783,9283,714--2,8873,0983,1163,3033,3442,9952,9982,8252,8613,0052,8812,923
EBITDA Margin-100.0%-0.81*--0.82*0.82*0.79*--0.63*0.63*0.63*0.65*0.64*0.62*0.60*0.62*0.65*0.70*0.73*0.74*
Interest Expenses---133---133---133---146---108--
Earnings Before Taxes5.2%4,0713,871-3,5513,8393,651-3,4322,6872,600-2,8112,9983,0392,6902,7362,5752,6292,7782,6822,728
EBT Margin-100.0%-0.76*-0.72*0.79*0.76*0.73*0.74*0.58*0.56*0.58*0.57*0.59*0.58*0.55*0.55*0.56*0.60*0.64*0.68*0.69*
Net Income4.0%2,9792,8642,6912,6782,9252,7732,6362,4351,9201,9132,1052,1512,3752,3862,1172,0331,8081,8601,9624,5164,413
Net Income Margin-100.0%-0.56*0.54*0.54*0.60*0.58*0.56*0.52*0.42*0.41*0.43*0.44*0.46*0.46*0.43*0.41*0.39*0.42*0.46*1.14*1.11*
Free Cashflow-100.0%-3,0782,9662,6502,6162,4772,2752,2251,8882,3782,5182,5813,0712,5212,4272,2292,0272,1372,3242,2622,242
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Assets-8.9%151,297166,039174,176178,432176,671205,918196,780186,774178,699160,652124,660125,759117,215137,93275,21579,41870,35071,61577,47670,36469,199
  Current Assets-11.2%116,366131,032139,078143,253141,451171,004161,762151,594144,849126,74689,28490,34981,786102,41739,56843,69234,46235,60541,88741,51540,301
    Cash Equivalents20.1%1,8801,5652,7202,1301,8802,046160,7901,4591,0819361,6331,3321,40585238,6341,21093899740,8331,4061,099
  Net PPE-2.3%430440456466482494505521528529579547539538544517500468449363380
  Goodwill0.0%10,49110,49110,48310,44710,48410,51610,52810,52910,54310,53410,79910,75610,74310,74310,74310,77410,79510,85010,8057,5697,569
Liabilities-10.9%123,479138,655147,297150,181148,670178,181169,381159,492151,912134,09698,30898,74890,376111,33449,05652,60443,86545,42851,51047,06846,076
  Current Liabilities-11.7%113,886129,044137,688140,573139,000168,459160,398150,417142,013124,22388,19888,63180,201101,05438,52341,91432,93534,27241,27338,15437,180
  Short Term Borrowings-100.0%-16.0016.0015.00--749749----------574--
Shareholder's Equity1.6%27,81827,38426,87928,25128,00227,73727,39927,28226,78726,55626,35227,01026,83926,59926,15926,81326,48526,18725,96523,29623,124
  Retained Earnings7.2%5,6075,2304,7476,1125,7985,4995,1526,0375,4355,2474,9965,7755,6695,4705,0095,7045,3375,0914,8555,3465,173
  Additional Paid-In Capital0.1%22,30822,28222,26222,23522,23222,20622,19021,20421,21921,19421,18621,15721,14921,12021,11321,10821,10921,06221,05417,92717,928
Accumulated Depreciation-25.6%8741,1751,1451,1111,0971,0711,0391,046980947961932894886868837844790761737727
Shares Outstanding0.0%359359-359359359-358358358-358358358-357357357-340339
Minority Interest---------24.0028.0032.0031.0031.0031.0030.0030.0030.0029.0047.00--
Float---------------------55,400
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q32018Q2
Cashflow From Operations1.0%3,1923,1593,0562,7432,7172,5992,4022,3942,0742,5612,7162,7753,2742,7612,6732,4642,2362,2852,4412,3912,316
  Share Based Compensation0.1%85.0085.0084.0077.0074.0074.0075.0083.0092.0095.0096.0072.0062.0078.0073.0011711997.0097.0066.0064.00
Cashflow From Investing102.4%12.00-484-489-396-31470.0058.00-61.30-164-166-175-139-142-147-152-1,987-1,971-1,920-1,889-59.80-32.60
Cashflow From Financing33.7%-28,391-42,801-25,381-10,895-4,50642,73169,909109,911102,02184,06047,247-2,514-2,664-2,757-2,340-2,289-2,057-642-1,080-984-961
  Dividend Payments1.2%3,1623,1262,6342,5972,5562,5152,1892,1672,1482,1302,1102,0742,0382,0011,6961,6781,6471,6172,1502,1242,110

CME Income Statement

2023-06-30
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Millions
3 Months Ended6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues    
Total Revenues$ 1,360.2$ 1,237.2$ 2,801.8$ 2,583.8
Expenses    
Compensation and benefits205.7185.3410.2370.5
Technology53.345.9104.691.8
Professional fees and outside services37.832.076.163.8
Amortization of purchased intangibles57.057.1113.8115.5
Depreciation and amortization32.333.064.266.5
Licensing and other fee agreements78.283.1162.9164.0
Other57.351.1117.7102.9
Total Expenses521.6487.51,049.5975.0
Operating Income838.6749.71,752.31,608.8
Non-Operating Income (Expense)    
Investment income1,568.2286.92,925.9360.0
Interest and other borrowing costs(40.2)(39.9)(80.1)(82.4)
Equity in net earnings of unconsolidated subsidiaries75.187.3153.3160.6
Other non-operating income (expense)(1,425.3)(217.3)(2,578.1)(264.0)
Total Non-Operating Income (Expense)177.8117.0421.0174.2
Income before Income Taxes1,016.4866.72,173.31,783.0
Income tax provision238.8204.2511.9409.5
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest(777.6)(662.5)(1,661.4)(1,373.5)
Net Income Attributable to Common Shareholders of CME Group$ 767.8$ 654.1$ 1,640.5$ 1,356.1
Earnings per Share Attributable to Common Shareholders of CME Group:    
Basic (in dollars per share)$ 2.14$ 1.82$ 4.57$ 3.78
Diluted (in dollars per share)$ 2.14$ 1.82$ 4.56$ 3.78
Weighted Average Number of Common Shares:    
Basic (in shares)358,940358,641358,937358,625
Diluted (in shares)359,429359,205359,371359,179
Clearing and transaction fees [Member]    
Revenues    
Total Revenues$ 1,118.3$ 1,024.6$ 2,318.5$ 2,162.7
Market data and information services    
Revenues    
Total Revenues163.1151.7328.9303.4
Other    
Revenues    
Total Revenues$ 78.8$ 60.9$ 154.4$ 117.7

CME Balance Sheet

2023-06-30
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2023
Dec. 31, 2022
Assets  
Cash and cash equivalents$ 1,880.1$ 2,720.1
Marketable securities106.796.0
Accounts receivable, net of allowance of $7.5 and $8.1599.4483.2
Other current assets (includes $5.2 and $4.9 in restricted cash)538.3529.8
Performance bonds and guaranty fund contributions113,241.6135,249.2
Total current assets116,366.1139,078.3
Property, net of accumulated depreciation and amortization of $874.1 and $1,145.2430.1455.5
Intangible assets—trading products[1]17,175.317,175.3
Intangible assets—other, net3,160.33,269.7
Goodwill10,490.710,482.5
Other assets (includes $0.0 and $0.1 in restricted cash)3,674.23,714.4
Total Assets151,296.7174,175.7
Liabilities and Equity  
Accounts payable50.9121.4
Short-term Debt0.016.0
Other current liabilities593.22,300.9
Performance bonds and guaranty fund contributions113,241.6135,249.2
Total current liabilities113,885.7137,687.5
Long-term debt3,423.83,422.4
Deferred income tax liabilities, net5,343.65,361.1
Other liabilities825.8826.0
Total Liabilities123,478.9147,297.0
Shareholders' Equity:  
Preferred stock, $0.01 par value, 10,000 shares authorized as of June 30, 2023 and December 31, 2022; 4,584 issued and outstanding as of June 30, 2023 and December 31, 20220.00.0
Additional paid-in capital22,307.622,261.6
Retained earnings5,606.84,746.8
Accumulated other comprehensive income (loss)(100.2)(133.3)
Total CME Group Shareholders’ Equity27,817.826,878.7
Total Liabilities and Equity151,296.7174,175.7
Class A Common Stock [Member]  
Shareholders' Equity:  
Common stock3.63.6
Class B Common Stock [Member]  
Shareholders' Equity:  
Common stock$ 0.0$ 0.0
[1]Trading products represent futures and options products acquired in our business combinations with CBOT Holdings, Inc., NYMEX Holdings, Inc. and The Board of Trade of Kansas City, Missouri, Inc. Clearing and transaction fees are generated through the trading of these products. These trading products, most of which have traded for decades, require authorization from the Commodity Futures Trading Commission (CFTC). Product authorizations from the CFTC have no term limits.
Terrence A. Duffy
3480
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.